Cargando…

Tumor Microenvironment-Mediated Immune Profiles Characterized by Distinct Survival Outcome and Immunotherapeutic Efficacy in Breast Cancer

Background: Numerous reports have highlighted that the tumor microenvironment (TME) is closely linked to survival outcome and therapeutic efficacy. However, a comprehensive investigation of the TME feature in breast cancer (BC) has not been performed. Methods: Here, we performed consensus clustering...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Lijun, Hu, Yaomin, Liu, Wenwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992709/ https://www.ncbi.nlm.nih.gov/pubmed/35401704 http://dx.doi.org/10.3389/fgene.2022.840348

Ejemplares similares

Pyroptosis-Mediated Molecular Subtypes are Characterized by Distinct Tumor Microenvironment Infiltration Characteristics in Breast Cancer
por: Xu, Lijun, et al.
Publicado: (2022)

Immunogenic cell death mediation patterns reveal novel paradigm for characterizing the immune microenvironment and immunotherapeutic responses in bladder cancer
por: Fu, Jialei, et al.
Publicado: (2022)

Comprehensive Profiling Reveals Distinct Microenvironment and Metabolism Characterization of Lung Adenocarcinoma
por: Li, Chang, et al.
Publicado: (2021)

Initial characterization of immune microenvironment in pheochromocytoma and paraganglioma
por: Jin, Bo, et al.
Publicado: (2022)

Nanomedicines targeting activation of STING to reshape tumor immune microenvironment and enhance immunotherapeutic efficacy
por: Chen, Shanshan, et al.
Publicado: (2023)

Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
por: Zhang, Lu, et al.
Publicado: (2021)

Cuproptosis scoring model predicts overall survival and assists in immunotherapeutic decision making in pancreatic carcinoma
por: Liu, Tijun, et al.
Publicado: (2022)

The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma
por: He, Wan, et al.
Publicado: (2022)

Characterization of tumor immune microenvironment and cancer therapy for head and neck squamous cell carcinoma through identification of a genomic instability-related lncRNA prognostic signature
por: Jing, Lijun, et al.
Publicado: (2022)

Novel Immune-Related Gene-Based Signature Characterizing an Inflamed Microenvironment Predicts Prognosis and Radiotherapy Efficacy in Glioblastoma
por: Ji, Hang, et al.
Publicado: (2022)

Exosomal microRNAs in cancer: Potential biomarkers and immunotherapeutic targets for immune checkpoint molecules
por: Alotaibi, Faizah
Publicado: (2023)

Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma
por: He, Wan, et al.
Publicado: (2022)

FAM46C as a Potential Marker for Pan-Cancer Prognosis and Predicting Immunotherapeutic Efficacy
por: Deng, Jiehua, et al.
Publicado: (2022)

Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy
por: Lin, Zhengjun, et al.
Publicado: (2022)

Tumor Immune Microenvironment Characterization in Hepatocellular Carcinoma Identifies Four Prognostic and Immunotherapeutically Relevant Subclasses
por: Gao, Xingxing, et al.
Publicado: (2021)

Definition of immune molecular subtypes with distinct immune microenvironment, recurrence, and PANoptosis features to aid clinical therapeutic decision-making
por: Qiang, Sufeng, et al.
Publicado: (2022)

Multiple epigenetic modification profiles reveal the tumor immune microenvironment and clinical outcomes of uveal melanoma
por: Nan, Xinshuai, et al.
Publicado: (2023)

Characterization of glycosylation regulator-mediated glycosylation modification patterns and tumor microenvironment infiltration in hepatocellular carcinoma
por: Zhao, Linlin, et al.
Publicado: (2022)

Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors
por: Sarantis, Panagiotis, et al.
Publicado: (2022)

Development of a Novel Immune-Related Gene Signature to Predict Prognosis and Immunotherapeutic Efficiency in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022)

Metabolism-Relevant Molecular Classification Identifies Tumor Immune Microenvironment Characterization and Immunotherapeutic Effect in Cervical Cancer
por: Li, Luyi, et al.
Publicado: (2021)

Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Kidney Renal Clear Cell Carcinoma
por: Qin, Huisheng, et al.
Publicado: (2022)

Comprehensive characterization of endoplasmic reticulum stress in bladder cancer revealing the association with tumor immune microenvironment and prognosis
por: Lin, Yuda, et al.
Publicado: (2023)

A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancer
por: Zhang, Zhihao, et al.
Publicado: (2022)

Characterization of the microenvironment in different immune-metabolism subtypes of cervical cancer with prognostic significance
por: Lai, Wujiang, et al.
Publicado: (2023)

An Immune-Related Gene Signature Can Predict Clinical Outcomes and Immunotherapeutic Response in Oral Squamous Cell Carcinoma
por: Zhang, Liyuan, et al.
Publicado: (2022)

The expression pattern of immune-related genes and characterization of tumor immune microenvironment: predicting prognosis and immunotherapeutic effects in cutaneous melanoma
por: Dong, Dong, et al.
Publicado: (2022)

Tumor Microenvironment Profiling Identifies Prognostic Signatures and Suggests Immunotherapeutic Benefits in Neuroblastoma
por: Feng, Chenzhao, et al.
Publicado: (2022)

The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer
por: Li, Jia, et al.
Publicado: (2022)

Editorial: New insights into antitumor mechanisms based on breast cancer immune microenvironment
por: Yao, Yan, et al.
Publicado: (2023)

Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments
por: Kester, Lennart, et al.
Publicado: (2022)

Identification of the pyroptosis-related prognostic gene signature and characterization of tumor microenvironment infiltration in triple-negative breast cancer
por: Liu, Ji, et al.
Publicado: (2022)

CMTM7 recognizes an immune-hot tumor microenvironment and predicts therapeutic response of immunotherapy in breast cancer well
por: Jiang, Xingyu, et al.
Publicado: (2022)

DNA methylation regulator-mediated modification pattern defines tumor microenvironment immune infiltration landscape in colon cancer
por: Yuan, Shijin, et al.
Publicado: (2022)

Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
por: Zhang, Chunyu, et al.
Publicado: (2021)

Bioresponsive and immunotherapeutic nanomaterials to remodel tumor microenvironment for enhanced immune checkpoint blockade
por: Fang, Tianxu, et al.
Publicado: (2023)

Peripheral blood markers predict immunotherapeutic efficacy in patients with advanced non-small cell lung cancer: A multicenter study
por: Liu, Shuai, et al.
Publicado: (2022)

Correlations Between the Characteristics of Alternative Splicing Events, Prognosis, and the Immune Microenvironment in Breast Cancer
por: Deng, Youyuan, et al.
Publicado: (2021)

N6-methyladenosine Regulator-Mediated Immune Genes Identify Breast Cancer Immune Subtypes and Predict Immunotherapy Efficacy
por: Zhang, Meng-Meng, et al.
Publicado: (2021)

RNA N6-Methyladenosine Regulators Contribute to Tumor Immune Microenvironment and Have Clinical Prognostic Impact in Breast Cancer
por: Mu, Lan-Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7cpfufmlt9lv0g2lbh6sq07k7p